We examined 21 biopsy samples gene expression of glioblastoma patients, which showed elevated expression of G-CSF, G-CSFR, and STAT3 at the transcriptome and proteomic levels compared to tumor-associated normal tissue (TANT), which might be considered diagnostic and prognostic biomarkers. This evidence concerns the gene STAT3 and glioblastoma.